Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
1
10%
Ph not_applicable
8
80%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (11.1%)
N/A8 (88.9%)

Trials by Status

terminated110%
completed880%
enrolling_by_invitation110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10